GALECTIN THERAPEUTICS INC Annual Return On Assets in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Galectin Therapeutics Inc quarterly/annual Return On Assets history and growth rate from 2012 to 2023.
  • Galectin Therapeutics Inc Return On Assets for the quarter ending June 30, 2024 was -170 %, a 15% increase year-over-year.
  • Galectin Therapeutics Inc annual Return On Assets for 2023 was -181 %, a 15.3% decline from 2022.
  • Galectin Therapeutics Inc annual Return On Assets for 2022 was -157 %, a 75.2% decline from 2021.
  • Galectin Therapeutics Inc annual Return On Assets for 2021 was -89.7 %, a 42.4% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -181 -24 -15.3% Jan 1, 2023 Dec 31, 2023
2022 -157 -67.5 -75.2% Jan 1, 2022 Dec 31, 2022
2021 -89.7 -26.7 -42.4% Jan 1, 2021 Dec 31, 2021
2020 -63 -29.7 -89.5% Jan 1, 2020 Dec 31, 2020
2019 -33.2 +122 +78.6% Jan 1, 2019 Dec 31, 2019
2018 -155 +32.8 +17.4% Jan 1, 2018 Dec 31, 2018
2017 -188 -70.7 -60.1% Jan 1, 2017 Dec 31, 2017
2016 -118 -40.9 -53.4% Jan 1, 2016 Dec 31, 2016
2015 -76.6 -28.9 -60.7% Jan 1, 2015 Dec 31, 2015
2014 -47.7 +99.3 +67.6% Jan 1, 2014 Dec 31, 2014
2013 -147 -68.9 -88.4% Jan 1, 2013 Dec 31, 2013
2012 -78 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.